Insider Deck research · News

VRTX stock news · Vertex Pharmaceuticals Incorporated

Latest Vertex Pharmaceuticals Incorporated (VRTX) stock news, headlines, and research context on Insider Deck. Market cap $123B.

News desk

Vertex Pharmaceuticals Incorporated wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

8 on the wireUpdated within the hour

MT Newswires·Wed, Aug 5, 3:12 PM

Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570

Vertex Pharmaceuticals (VRTX) has an average rating of overweight and mean price target of $563.21,

Insider Deck desk note

Last$484.83
Day+1.28%
SymbolVRTX

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on MT Newswires

Frequently asked questions

What is the latest news on VRTX?

The VRTX news desk aggregates recent headlines with research context for Vertex Pharmaceuticals Incorporated.

Where can I research VRTX on Insider Deck?

Vertex Pharmaceuticals Incorporated (VRTX) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.